Hypoxia selects for high-metastatic Lewis lung carcinoma cells overexpressing Mcl-1 and exhibiting reduced apoptotic potential in solid tumors.

Abstract:

:Low oxygen tension (hypoxia) is a common feature of solid tumors and stimulates the expressions of a variety of genes including those related to angiogenesis, apoptosis and endoplasmic reticulum (ER) stress response. Here we show a close correlation between metastatic potential and the resistance to hypoxia- and ER stress-induced apoptosis among the cell lines with differing metastatic potential derived from Lewis lung carcinoma. An apoptosis-specific expression profiling and immunoblot analyses revealed that the expression of antiapoptotic Mcl-1 increased as the resistance to apoptosis increased. Downregulation of the Mcl-1 expression in the high-metastatic cells by Mcl-1 small interfering RNA increased the sensitivity to hypoxia-induced apoptosis and decreased the metastatic ability. The hypoxia-induced apoptosis was not associated with p53 accumulation, although at present it is not possible to conclude that apoptosis-induced apoptosis is p53-independent. There was no correlation between the expression levels of ER stress-response proteins GADD153, GRP78 and ORP150 and the resistance to hypoxia or ER stresses. In vitro, small numbers of the high-metastatic cells overtook the low-metastatic cells after exposure to several rounds of hypoxia and reoxygenation. In solid tumors initially established from equal mixtures, the proportion of the high-metastatic cells to low-metastatic cells was significantly higher in hypoxic areas. Moreover, the high-metastatic cells were overtaking the low-metastatic cells in some of the tumors. Thus, tumor hypoxia and ER stress may provide a physiological selective pressure for the expansion of the high-metastatic cells overexpressing Mcl-1 and exhibiting reduced apoptotic potential in solid tumors.

journal_name

Oncogene

journal_title

Oncogene

authors

Koshikawa N,Maejima C,Miyazaki K,Nakagawara A,Takenaga K

doi

10.1038/sj.onc.1209128

subject

Has Abstract

pub_date

2006-02-09 00:00:00

pages

917-28

issue

6

eissn

0950-9232

issn

1476-5594

pii

1209128

journal_volume

25

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • p53 inhibits mRNA 3' processing through its interaction with the CstF/BARD1 complex.

    abstract::The mechanisms involved in the p53-dependent control of gene expression following DNA damage have not been completely elucidated. Here, we show that the p53 C terminus associates with factors that are required for the ultraviolet (UV)-induced inhibition of the mRNA 3' cleavage step of the polyadenylation reaction, suc...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.29

    authors: Nazeer FI,Devany E,Mohammed S,Fonseca D,Akukwe B,Taveras C,Kleiman FE

    更新日期:2011-07-07 00:00:00

  • The HIF1alpha-inducible pro-cell death gene BNIP3 is a novel target of SIM2s repression through cross-talk on the hypoxia response element.

    abstract::The short isoform of single-minded 2 (SIM2s), a basic helix-loop-helix/PAS (bHLH/PAS) transcription factor, is upregulated in pancreatic and prostate tumours; however, a mechanistic role for SIM2s in these cancers is unknown. Microarray studies in prostate DU145 cells identified the pro-cell death gene, BNIP3 (Bcl-2/a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.228

    authors: Farrall AL,Whitelaw ML

    更新日期:2009-10-15 00:00:00

  • Characterization of Wnt-1 and Wnt-2 induced growth alterations and signaling pathways in NIH3T3 fibroblasts.

    abstract::Members of the Wnt family induce mouse mammary tumors and partially transform mammary epithelial cells in culture. However, their mechanism of transformation remains to be elucidated. In NIH3T3 mouse embryo fibroblasts, a standard transformation model, Wnt-1 and Wnt-2 were shown to induce altered properties including ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201797

    authors: Bafico A,Gazit A,Wu-Morgan SS,Yaniv A,Aaronson SA

    更新日期:1998-05-28 00:00:00

  • The path to metastatic mouse models of colorectal cancer.

    abstract::The study and comprehension of the molecular mechanisms underlying cancer biology strongly rely on mouse modeling. An ideal mouse model should have molecular, histopathological, and etiological characteristics as close as possible to those of the corresponding human tumors. Among solid tumors, colorectal cancer (CRC) ...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/s41388-018-0155-x

    authors: Romano G,Chagani S,Kwong LN

    更新日期:2018-05-01 00:00:00

  • Mouse models in tumor suppression.

    abstract::Genetic lesions found in tumors are often targeted to the negative growth regulatory tumor suppressor genes. Much of our understanding of tumor suppressor gene function is derived from experimental manipulations in cultured cells. Recently, however, the generation of mice with germ line tumor suppressor gene mutations...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1202573

    authors: Ghebranious N,Donehower LA

    更新日期:1998-12-24 00:00:00

  • Correction: FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial-mesenchymal transition, and metastasis in FGFR1-amplified lung cancer.

    abstract::An amendment to this paper has been published and can be accessed via a link at the top of the paper. ...

    journal_title:Oncogene

    pub_type: 已发布勘误

    doi:10.1038/s41388-020-01441-6

    authors: Wang K,Ji W,Yu Y,Li Z,Niu X,Xia W,Lu S

    更新日期:2020-10-01 00:00:00

  • FOXA1 inhibits prostate cancer neuroendocrine differentiation.

    abstract::Neuroendocrine prostate cancer (NEPC) has increasingly become a clinical challenge. The mechanisms by which neuroendocrine (NE) cells arises from prostate adenocarcinoma cells are poorly understood. FOXA1 is a transcription factor of the forkhead family that is required for prostate epithelial differentiation. In this...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.50

    authors: Kim J,Jin H,Zhao JC,Yang YA,Li Y,Yang X,Dong X,Yu J

    更新日期:2017-07-13 00:00:00

  • BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter.

    abstract::BCL11 genes play crucial roles in lymphopoiesis and have been associated with hematopoietic malignancies. Specifically, disruption of the BCL11B (B-cell chronic lymphocytic leukemia/lymphoma 11B) locus is linked to T-cell acute lymphoblastic leukemia, and the loss of heterozygosity in mice results in T-cell lymphoma. ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208904

    authors: Cismasiu VB,Adamo K,Gecewicz J,Duque J,Lin Q,Avram D

    更新日期:2005-10-13 00:00:00

  • Gene structure of the human MET proto-oncogene.

    abstract::By direct sequencing of cosmids using primers designed from the known cDNA sequence, we identified 19 exons in the human MET proto-oncogene, and sequenced the corresponding 5' and 3' exon-intron junctions. By homology search in the database of the Washington University Genome Sequence Center (GSC), we identified one a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201338

    authors: Duh FM,Scherer SW,Tsui LC,Lerman MI,Zbar B,Schmidt L

    更新日期:1997-09-25 00:00:00

  • A RAS-CaMKKβ-AMPKα2 pathway promotes senescence by licensing post-translational activation of C/EBPβ through a novel 3'UTR mechanism.

    abstract::Oncogene-induced senescence (OIS) is an intrinsic tumor suppression mechanism that requires the p53 and RB pathways and post-translational activation of C/EBPβ through the RAS-ERK cascade. We previously reported that in transformed/proliferating cells, C/EBPβ activation is inhibited by G/U-rich elements (GREs) in its ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0190-7

    authors: Basu SK,Gonit M,Salotti J,Chen J,Bhat A,Gorospe M,Viollet B,Claffey KP,Johnson PF

    更新日期:2018-06-01 00:00:00

  • Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via αvβ3/pp60src/pp125FAK pathway.

    abstract::Syndecan-1 is a heparan sulfate proteoglycan (HSPG) commonly upregulated in AIDS-related B lymphoid malignancies. Tat is the main HIV-1 transactivating factor that has a major role in the pathogenesis of AIDS-related lymphomas (ARL) by engaging heparan sulfate proteoglycans (HSPGs), chemokine receptors and integrins a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.420

    authors: Urbinati C,Grillo E,Chiodelli P,Tobia C,Caccuri F,Fiorentini S,David G,Rusnati M

    更新日期:2017-05-04 00:00:00

  • Preferential selection of MnSOD transcripts in proliferating normal and cancer cells.

    abstract::Manganese superoxide dismutase (MnSOD) is a nuclear encoded and mitochondrial matrix-localized redox enzyme that is known to regulate the cellular redox environment. Cellular redox environment changes during transitions between quiescent and proliferative cycles. Human MnSOD has two poly(A) sites resulting in two tran...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.325

    authors: Chaudhuri L,Nicholson AM,Kalen AL,Goswami PC

    更新日期:2012-03-08 00:00:00

  • The protein-tyrosine phosphatase DEP-1 modulates growth factor-stimulated cell migration and cell-matrix adhesion.

    abstract::Density-enhanced protein-tyrosine phosphatase-1 (DEP-1 also CD148) is a transmembrane molecule with a single intracellular PTP domain. It has recently been proposed to function as a tumor suppressor. We have previously shown that DEP-1 dephosphorylates the activated platelet-derived growth factor (PDGF) beta-receptor ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206652

    authors: Jandt E,Denner K,Kovalenko M,Ostman A,Böhmer FD

    更新日期:2003-07-03 00:00:00

  • Overexpression of Aurora-A potentiates HRAS-mediated oncogenic transformation and is implicated in oral carcinogenesis.

    abstract::Aurora kinases are known to play a key role in maintaining mitotic fidelity, and overexpression of aurora kinases has been noted in various tumors. Overexpression of aurora kinase activity is thought to promote cancer development through a loss of centrosome or chromosome number integrity. Here we observed augmentatio...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208293

    authors: Tatsuka M,Sato S,Kitajima S,Suto S,Kawai H,Miyauchi M,Ogawa I,Maeda M,Ota T,Takata T

    更新日期:2005-02-03 00:00:00

  • The Rafts of the Medusa: cholesterol targeting in cancer therapy.

    abstract::In this issue of Oncogene, Mollinedo and co-workers present promising evidence that cholesterol-sensitive signaling pathways involving lipid rafts can be therapeutically targeted in multiple myeloma. Because the pathways considered in their study are used by other types of tumor cells, one implication of this report i...

    journal_title:Oncogene

    pub_type: 评论,杂志文章

    doi:10.1038/onc.2010.132

    authors: Freeman MR,Di Vizio D,Solomon KR

    更新日期:2010-07-01 00:00:00

  • Expression of SCC-S2, an antiapoptotic molecule, correlates with enhanced proliferation and tumorigenicity of MDA-MB 435 cells.

    abstract::SCC-S2/GG2-1/NDED is a recently discovered antiapoptotic molecule induced by the activation of the transcription factor NF-kappaB. Here we have examined a role of SCC-S2 in cell growth regulation in vitro and in vivo. Western blotting using an antipeptide antibody revealed endogenous SCC-S2 as a approximately 21 kDa c...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207123

    authors: Kumar D,Gokhale P,Broustas C,Chakravarty D,Ahmad I,Kasid U

    更新日期:2004-01-15 00:00:00

  • Src family kinases mediate cytoplasmic retention of activated STAT5 in BCR-ABL-positive cells.

    abstract::Persistent activation of the Abl tyrosine kinase in the BCR-ABL fusion protein is the major cause of chronic myeloid leukemia (CML). Among many other substrates BCR-ABL phosphorylates STAT5 and Src family kinases (SFK). Activated pSTAT5 is essential for initial transformation and maintenance of the disease. Cytokine-i...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.369

    authors: Chatain N,Ziegler P,Fahrenkamp D,Jost E,Moriggl R,Schmitz-Van de Leur H,Müller-Newen G

    更新日期:2013-08-01 00:00:00

  • Human oncogenes detected by a defined medium culture assay.

    abstract::Oncogenes in DNAs from human tumor cell lines have been detected by a new transformation assay. Cellular DNAs are transfected into NIH3T3 murine fibroblasts, and transformed cells are selected by maintaining cell cultures in a defined medium lacking platelet-derived or fibroblast growth factors. DNAs from eight of 17 ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Zhan X,Culpepper A,Reddy M,Loveless J,Goldfarb M

    更新日期:1987-01-01 00:00:00

  • Depletion of PDGF from serum inhibits growth of AIDS-related and sporadic Kaposi's sarcoma cells in culture.

    abstract::We have examined the mitogenic potential of platelet-derived growth factor (PDGF) on AIDS (acquired immune deficiency syndrome)-related and sporadic Kaposi's sarcoma cells in comparison to fibroblasts at physiological and subphysiological calcium concentrations of the culture medium. At low calcium concentrations in t...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Roth WK,Werner S,Schirren CG,Hofschneider PH

    更新日期:1989-04-01 00:00:00

  • Oncogenic HRAS suppresses clusterin expression through promoter hypermethylation.

    abstract::Silencing of gene expression by methylation of CpG islands in regulatory elements is frequently observed in cancer. However, an influence of the most common oncogenic signalling pathways onto DNA methylation has not yet been investigated thoroughly. To address this issue, we identified genes suppressed in HRAS-transfo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209502

    authors: Lund P,Weisshaupt K,Mikeska T,Jammas D,Chen X,Kuban RJ,Ungethüm U,Krapfenbauer U,Herzel HP,Schäfer R,Walter J,Sers C

    更新日期:2006-08-10 00:00:00

  • Regulation of mitotic exit by the RNF8 ubiquitin ligase.

    abstract::RNF8 is a ubiquitin ligase with a FHA domain near its N terminus, and a RING-finger domain at its C terminus, through which it recruits several ubiquitin-conjugating enzymes. In metazoans, only the mitotic checkpoint regulator CHFR shares this domain architecture. Here we show that RNF8 is a nuclear protein that follo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210782

    authors: Plans V,Guerra-Rebollo M,Thomson TM

    更新日期:2008-02-28 00:00:00

  • Regulation of Laloo by the Xenopus C-terminal Src kinase (Xcsk) during early vertebrate development.

    abstract::Mesoderm formation in the frog, Xenopus laevis, is dependent on the activity of one or more members of the Src family kinases; the molecular interactions underlying this requirement are not well understood. The C-terminal Src Kinase (Csk) is a potent inhibitor of Src activity, and is required for normal mammalian deve...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204672

    authors: Song Y,Cohler AN,Weinstein DC

    更新日期:2001-08-23 00:00:00

  • Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma.

    abstract::In classical Hodgkin lymphoma the malignant Hodgkin/Reed-Sternberg (HRS) cells characteristically constitute only a small minority of the tumour load. Their origin has been debated for decades, but on the basis of rearrangement and somatic hypermutations of their immunoglubulin (Ig) genes, HRS cells are now ascribed t...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205629

    authors: Hertel CB,Zhou XG,Hamilton-Dutoit SJ,Junker S

    更新日期:2002-07-25 00:00:00

  • Interaction of ETS-1 and ERGB/FLI-1 proteins with DNA is modulated by spacing between multiple binding sites as well as phosphorylation.

    abstract::ETS is a family of transcription factors that contain a highly conserved ETS DNA binding domain. Various members of the ETS family are expressed in cells of hematopoietic lineage. ETS-1, ETS-2 and ERGB/FLI-1 are expressed at high levels in T-lymphocytes. HIV-1 infects T-cells and it has been shown that its LTR contain...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Hodge DR,Robinson L,Watson D,Lautenberger J,Zhang XK,Venanzoni M,Seth A

    更新日期:1996-01-04 00:00:00

  • miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer.

    abstract::The disabled homolog 2 (DAB2) gene was recently identified as a tumor suppressor gene with its expression downregulated in multiple cancer types. The role of DAB2 in lung tumorigenesis, however, is not fully characterized, and the mechanisms of DAB2 dysregulation in lung cancer are not defined. Here we show that low D...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.381

    authors: Du L,Zhao Z,Ma X,Hsiao TH,Chen Y,Young E,Suraokar M,Wistuba I,Minna JD,Pertsemlidis A

    更新日期:2014-08-21 00:00:00

  • Impaired DNA damage-induced nuclear Rad51 foci formation uniquely characterizes Fanconi anemia group D1.

    abstract::Fanconi anemia is a hereditary cancer susceptibility disorder characterized at the cellular level by spontaneous chromosomal instability and specific hypersensitivity to DNA cross-linking agents such as mitomycin C. This phenotype suggests a possible role for the Fanconi anemia proteins in the repair of DNA lesions in...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205656

    authors: Godthelp BC,Artwert F,Joenje H,Zdzienicka MZ

    更新日期:2002-07-25 00:00:00

  • The phosphatidylinositol 3' kinase pathway is required for the survival signal of leukocyte tyrosine kinase.

    abstract::Leukocyte tyrosine kinase (LTK) is a receptor tyrosine kinase which belongs to the insulin receptor superfamily and is mainly expressed in pre-B lymphocytes and neuronal tissues. Recently, we demonstrated that LTK utilizes Shc and IRS-1 as two major substrates and while both equally activate the Ras pathway, only IRS-...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201153

    authors: Ueno H,Honda H,Nakamoto T,Yamagata T,Sasaki K,Miyagawa K,Mitani K,Yazaki Y,Hirai H

    更新日期:1997-06-26 00:00:00

  • Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes.

    abstract::Alternative splicing is a widespread process contributing to structural transcript variation and proteome diversity. In cancer, the splicing process is commonly disrupted, resulting in both functional and non-functional end-products. Cancer-specific splicing events are known to contribute to disease progression; howev...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2015.318

    authors: Sveen A,Kilpinen S,Ruusulehto A,Lothe RA,Skotheim RI

    更新日期:2016-05-12 00:00:00

  • 2-Methoxyestradiol induces apoptosis in Ewing sarcoma cells through mitochondrial hydrogen peroxide production.

    abstract::The Ewing sarcoma is the second most common bone tumor in children and young adults. Despite the advances in therapy, the 5-year survival rate for patients with metastatic disease is poor, indicating the need for alternative treatments. Here, we report that 2-methoxy-estradiol (2-Me), a natural estrogen metabolite, in...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206356

    authors: Djavaheri-Mergny M,Wietzerbin J,Besançon F

    更新日期:2003-05-01 00:00:00

  • Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface.

    abstract::The C-type lectin domain containing group 14 family members CLEC14A and CD93 are proteins expressed by endothelium and are implicated in tumour angiogenesis. CD248 (alternatively known as endosialin or tumour endothelial marker-1) is also a member of this family and is expressed by tumour-associated fibroblasts and pe...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.214

    authors: Khan KA,Naylor AJ,Khan A,Noy PJ,Mambretti M,Lodhia P,Athwal J,Korzystka A,Buckley CD,Willcox BE,Mohammed F,Bicknell R

    更新日期:2017-11-02 00:00:00